Impact of preoperative arterial and venous diameter on achievement of the adequate blood flow in arteriovenous fistula for hemodialysis

Gjorgjievski, Nikola; Dzekova‐Vidimliski, Pavlina; Trajcheska, Lada; Stojanoska, Ana; Selim, Gjulshen; Rambabova‐Bushljetik, Irena; Nikolov, Igor; Gjorgievska, Juija; Janevski, Zoran; Muharremi, Shkleqim; Dejanov, Petar; Spasovski, Goce; Šikole, Aleksandar; Ivanovski, N

doi:10.1111/1744-9987.13570

Cited by 5 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is ongoing debate on whether female sex is a risk factor for AVFT. Gjorgjievski et al [41] found that females are more likely to develop AVFT because they have smaller average preoperative arterial diameters and are less likely to achieve adequate BF. After AVF construction for 4 weeks, 12% of the female participants and 63% of their male counterparts achieved adequate BF, defined as 600 mL/min (p = 0.001).…”

Section: Discussionmentioning

confidence: 99%

Risk Factors for Arteriovenous Fistula Thrombus Development: A Systematic Review and Meta-Analysis

Zhang

et al. 2022

Kidney Blood Press Res

View full text Add to dashboard Cite

Background: Risk factors like female sex, fistula location, hypertension, albumin, diabetes, arteriovenous graft (AVG), age, and other factors are related to arteriovenous fistula thrombus (AVFT), but the consistency and magnitude of their associations have not been confirmed by meta-analysis. Objectives: The purpose of this study was to provide a comprehensive and up-to-date synthesis of evidence on the association between potential risk factors and AVFT. Methods: In this systematic review and meta-analysis, PubMed, Embase, Cochrane Library, and Web of Science databases were searched for articles published up to April 20th, 2022, and cohort, cross-sectional, and case-control studies examining the association (odds ratio [OR]) between potential risk factors and AVFT were identified. The other inclusion criteria were sufficient data for analysis and nonoverlapping datasets, excluding reviews, meta-analyses, and articles with overlapping datasets. Extracted variables included first author, publication year, study type, sample size, percentage of women, vascular access type, risk or protective factors, and measure of association (adjusted estimates of effect of all risk factors). The study protocol is registered at PROSPERO (CRD42020201884) and followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results: Among the 27 identified studies, data from 24 cohort, 2 case-control, and 1 cross-sectional study were included in this review. When compared to non-AVFT, our data showed that the significant risk factors were AVG (pooled OR = 6.28, 95% CI = 1.79–22.02, p = 0.004, I2 = 87%), age (pooled OR = 1.06, 95% CI = 1.00–1.13, p = 0.05, I2 = 98%), female sex (pooled OR = 2.62, 95% CI = 2.56–2.69, p < 0.00001, I2 = 0%), C-reactive protein (pooled OR = 1.18, 95% CI = 1.08–1.30, p = 0.0005, I2 = 90%), fistula site (distal) (pooled OR = 3.64, 95% CI = 1.74–7.62, p = 0.0006, I2 = 47%), hypertension (pooled OR = 1.21, 95% CI = 1.00–1.47, p = 0.05, I2 = 46%), CD34+KDR+ cell (pooled OR = 1.85, 95% CI = 1.33–2.57, p = 0.0002, I2 = 0%), and eprex use (pooled OR = 5.36, 95% CI = 1.82–15.77, p = 0.002, I2 = 0%). Conclusions: The meta-analysis suggests that AVG, age, female sex, CRP level, fistula site (distal), hypertension, CD34+KDR+ cell, and the use of eprex are independent risk factors for AVFT. Therefore, clinical medical staff should treat these risk factors carefully, identify them early, and prevent them early to reduce the occurrence of AVFT.

show abstract

Section: Discussionmentioning

confidence: 99%